In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA<sub>1c</sub> vs. daily degludec at 26 wk.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37782923.
- Also identified by DOI 10.7326/J23-0078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lingvay I, Asong M, Desouza C, et al. <b>Once-weekly insulin icodec vs once-daily insulin degludec in adults with insulin-naive type 2 diabetes: the ONWARDS 3 randomized clinical trial.</b> JAMA. 2023;330:228-237. 37354562.
Medical subject headings
- Diabetes Mellitus, Type 2